UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2016
Commission File Number: 001-37891
AC IMMUNE SA
(Exact name of registrant as specified in its charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form 20-F | X | Form 40-F |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
| Yes | No | X |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
| Yes | No | X |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AC IMMUNE SA
| |||||
| By: | /s/ Andrea Pfeifer | ||||
| Name: | Andrea Pfeifer | ||||
| Title: | Chief Executive Officer | ||||
| By: | /s/ George Pavey | ||||
| Name: | George Pavey | ||||
| Title: | Chief Financial Officer | ||||
Date: October 13, 2016
EXHIBIT INDEX
| Exhibit Number | Description |
| 99.1 | Invitation to the Ordinary Shareholders’ Meeting |
| 99.2 | Instructions on How to Become a Holder of Record |
| 99.3 | 2016 Annual General Meeting Proxy Card |
| 99.4 | Statutory Financial Statements (Swiss CO) 1 January – 31 December 2015 |
| 99.5 | Report of the Statutory Auditor on the Financial Statements |
| 99.6 | Financial Statements (IFRS) as at and for the years ended December 31, 2015 and 2014 |
| 99.7 | Report of Independent Registered Public Accounting Firm |
| 99.8 | 2016 Stock Option and Incentive Plan |